Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Big Names in Biotech Seek $1M to Build Life-Size Statue of Legend Henri Termeer

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

The effort was announced last week by the Henri A. Termeer Tribute Committee. Source: BioSpace

Continue ReadingBig Names in Biotech Seek $1M to Build Life-Size Statue of Legend Henri Termeer

Takeda Becomes the Latest to Notch an Alzheimer's Failure Under Its Belt

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

Another experimental Alzheimer's disease treatment has failed in a late-stage study. Source: BioSpace

Continue ReadingTakeda Becomes the Latest to Notch an Alzheimer's Failure Under Its Belt

Rumor Alert: Allergan in Talks to Buy Out KaNDy Therapeutics in $400M Deal

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

KaNDy Therapeutics is a clinical-stage company that is focused on female sex-hormone related conditions. Source: BioSpace

Continue ReadingRumor Alert: Allergan in Talks to Buy Out KaNDy Therapeutics in $400M Deal

What You Need to Know About Immune-Onc Therapeutics

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

Immune-Onc Therapeutics launched in September 2016 and is headquartered in Palo Alto, California. Source: BioSpace

Continue ReadingWhat You Need to Know About Immune-Onc Therapeutics

At Last: Eli Lilly Publishes Data for Catastrophic Alzheimer's Trial

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

Lilly finally revealed the data in the New England Journal of Medicine. Source: BioSpace

Continue ReadingAt Last: Eli Lilly Publishes Data for Catastrophic Alzheimer's Trial

Cellectis CEO Provides Update on UCART Programs and ‘Laser Focus’ of Company in 2018

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

After a brief stumble with UCART123 that resulted in a clinical hold last year, Cellectis is moving on with its study. Source: BioSpace

Continue ReadingCellectis CEO Provides Update on UCART Programs and ‘Laser Focus’ of Company in 2018

Novartis Buys Access to Spark's Landmark Gene Therapy Drug With $170M Deal

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

Spark won approval on Dec. 2017 as a one-time gene therapy to restore functional vision in children and adult patients with biallelic mutations of the RPE65. Source: BioSpace

Continue ReadingNovartis Buys Access to Spark's Landmark Gene Therapy Drug With $170M Deal

Former Merrimack, Sanofi Execs Launch Boston Cancer Startup

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

Biotech and pharma execs Robert Mulroy and Dr. Debasish Roychowdhury announced today the launch of Partner Therapeutics, or PTx. Source: BioSpace

Continue ReadingFormer Merrimack, Sanofi Execs Launch Boston Cancer Startup

UK's Dechra Spends $422.1M on Two Dutch Animal Pharmas

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:BioPharma

The company struck the cash-and-share deals to boost its presence in Europe. Source: BioSpace

Continue ReadingUK's Dechra Spends $422.1M on Two Dutch Animal Pharmas

EMA Recommended More Drugs for Marketing Authorizations in 2017

  • Post author:Sam
  • Post published:January 24, 2018
  • Post category:Drug Industry Daily

The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended marketing authorizations for 92 drugs and biologics in 2017, an increase from 81 in 2016 but down from…

Continue ReadingEMA Recommended More Drugs for Marketing Authorizations in 2017
  • Go to the previous page
  • 1
  • …
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.